Health Care & Life Sciences » Pharmaceuticals | Adcock Ingram Holdings Ltd.

Adcock Ingram Holdings Ltd. | Mutual Funds

Mutual Funds that own Adcock Ingram Holdings Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
First State Investments ICVC - Global Emerging Markets Fd.
2,375,995
1.35%
0
1.37%
01/31/2018
First State Investments ICVC - Glb. Em. Mrkts. Sustainability
1,476,436
0.84%
0
1.29%
01/31/2018
Vanguard Emerging Markets Stock Index Fund
1,157,925
0.66%
0
0.01%
07/31/2018
iShares Core MSCI Emerging Markets ETF
1,080,482
0.62%
0
0.01%
09/05/2018
Vanguard Total International Stock Index Fund
1,004,318
0.56%
0
0%
07/31/2018
DFA Emerging Markets Small Cap Series
839,261
0.48%
-9,557
0.06%
01/31/2018
720,646
0.41%
0
1.34%
01/31/2018
Centaur MET Flexible Fund
718,995
0.41%
221,495
2.24%
12/31/2017
DFA Emerging Markets Core Equity Portfolio
714,087
0.41%
42,646
0.01%
04/30/2018
Centaur MET Balanced Fund
414,505
0.24%
81,500
1.9%
12/31/2017

About Adcock Ingram Holdings

View Profile
Address
1 New Road
Midrand GT 1682
South Africa
Employees -
Website http://www.adcock.co.za
Updated 07/08/2019
Adcock Ingram Holdings Ltd. is a pharmaceutical company. It operates through the following segments: Over the Counter, Consumer, Prescription and Hospital. The Over the Counter segment focuses primarily on brands sold predominantly in the pharmacy market, where the pharmacist plays a role in the product choice.